Patent · US Active

Markers for mood disorders

US10745736B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 1, 2015
Grant dateAug 18, 2020
Priority date
Expiry dateOct 1, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/304
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Disclosed is a method for diagnosing a mood disorder or susceptibility to a mood disorder, including depressive disorders and bipolar disorder, from a biological sample taken from a subject. The method includes detecting markers of monoamine oxidase-A (MAO-A) in the biological sample; determining MAO-A concentration from the markers; and correlating the MAO-A concentration in the biological sample to a control group which does not have a mood disorder in order to diagnose or determine susceptibility to the mood disorder in the subject. Also disclosed is a method of detecting peripheral markers of MAO-A for the diagnosis of a mood disorder or susceptibility to a mood disorder. Also provided are polypeptide markers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.